Eli Lilly

Lilly Covid-19 Trial Halted on Safety Concern

US medical research agency the National Institutes of Health (NIH) has paused a Phase 3 study on Eli Lilly’s Covid-19 antibody treatment on a potential safety concern.

Continuous Pharmaceutical Manufacturing

Technology and Innovation in the Pharmaceutical Industry

Eli Lilly in Immunology Pact with Sitryx

Lilly to Build Injectables Plant in North Carolina

Lilly Boosts Dermatology with Dermira Buy

US to Allow Drug Reimports from Canada

Lilly in $400 Million Expansion at Indianapolis

Bayer Animal Health and VLPbio to Collaborate

Injecting Growth and Innovation

Continuous Processing

Lilly Wins Alimta Appeal

Bayer and Elanco Animal Health Link-up?

Lilly and Avidity Biosciences Partner on New Drugs

The Need for Innovation in Pharmaceutical Manufacturing

Lilly Launches cut-price Generic Insulin in US

Eli Lilly to Buy Loxo for $8 Billion

DCAT Announces New Board of Directors

Lilly and Chugai in Diabetes Drug Pact

Eli Lilly Plans IPO for Elanco

Eli Lilly to Buy AurKa Pharma and ARMO

Ex-Lilly Executive Confirmed as US Health Secretary

US Health Secretary Pick Hammered on Price Gouging

Former Lilly President to Head US Health Department

FDA Approves Lilly Breast Cancer Drug

Lilly and CureVac in Cancer Vaccines Pact

Lilly to cut 3,500 jobs by Year-end

Eli Lilly and Nektar Develop Autoimmune Therapy

UK Supreme Court Upholds Lily Alimta Patent

Drug Patent Losses Worth Billions Seen in 2017

Pharma Chiefs Call for Decision on EMA

Lilly to Invest $850 Million in US Operations

FDA Approves Novartis Breast Cancer Drug

US Drugmakers Urge Tax Code Reform

Trump Discusses Issues With Drugmakers